Twenty-Two Desserts, Inc.

BROOKLYN, NY · CIK 0001983549 · Biotech

Biotech screening platform using intelligent algorithms for compound and variant evaluation

twentytwo.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$1.4M
2 Form D · Nov 2025
11 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$630,000
Private capital raisedForm D · SEC$747,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2105Douleur Therapeutics Inc——
2106YEWSAVIN, INC.——
2107NEUROTHERANOSTICS, INC.——
2108Twenty-Two Desserts, Inc.—$1.4M
2109AVIVA BIOSCIENCES CORP—$500K
2110BE Biopharma——
2111FRUGI BIOTECHNOLOGY INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Pooja BavishiDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.